{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T22:29:48Z","timestamp":1775946588583,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1097\/igc.0b013e31823c2469","type":"journal-article","created":{"date-parts":[[2012,1,7]],"date-time":"2012-01-07T07:43:25Z","timestamp":1325922205000},"page":"303-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Age-Specific Seroprevalence of Human Papillomavirus 16, 18, 31, and 58 in Women of a Rural Town of Colombia"],"prefix":"10.1016","volume":"22","author":[{"given":"Astrid M.","family":"Bedoya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela M.","family":"Gaviria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Baena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Borrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego F.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba L.","family":"Combita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Grisales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria I.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e31823c2469_bb0005","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"IntJ Cancer."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0010","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jnci\/djq001","article-title":"Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2\/3: critical role of duration of infection","volume":"102","author":"Rodriguez","year":"2010","journal-title":"J Natl Cancer Inst."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jnci\/djp534","article-title":"Impact of human papillomavirus (HPV)-6\/11\/16\/18 vaccine on all HPV-associated genital diseases in young women","volume":"102","author":"Munoz","year":"2010","journal-title":"J Natl Cancer Inst."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0030","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.298.7.743","article-title":"Effect of human papillomavirus 16\/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial","volume":"298","author":"Hildesheim","year":"2007","journal-title":"JAMA."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0035","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.vaccine.2011.01.001","article-title":"HPV16\/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection","volume":"29","author":"Kemp","year":"2011","journal-title":"Vaccine."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0040","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1016\/j.vaccine.2008.07.041","article-title":"Seroepidemiology as basis for design of a human papillomavirus vaccination program","volume":"26","author":"Ryding","year":"2008","journal-title":"Vaccine."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0045","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/OLQ.0b013e3181bce102","article-title":"The use of human papillomavirus seroepidemiology to inform vaccine policy","volume":"36","author":"Schiffman","year":"2009","journal-title":"Sex Transm Dis."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0050","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.trstmh.2011.01.004","article-title":"Prevalence of specif ic herpes simplex virus-2 antibodies and associated factors in women of a rural town of Colombia","volume":"105","author":"Sierra","year":"2011","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0055","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/sj.bjc.6600442","article-title":"Prevalence and determinants of HPV infection among Colombian women with normal cytology","volume":"87","author":"Molano","year":"2002","journal-title":"Br J Cancer."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0060","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/ijc.10153","article-title":"Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in Colombian women with invasive cervical cancer","volume":"97","author":"Combita","year":"2002","journal-title":"Int J Cancer."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0065","series-title":"Applied Logistic Regression","author":"Hosmer","year":"2000"},{"key":"10.1097\/IGC.0b013e31823c2469_bb0070","unstructured":"R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2011. Available at: http:\/\/www.R-project.org. Accessed February 25, 2011."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0075","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1158\/1055-9965.EPI-10-0336","article-title":"Seroprevalence of antibodies against human papillomavirus (HPV) types 16 and 18 in four continents: the International Agency for Research on Cancer HPV Prevalence Surveys","volume":"19","author":"Vaccarella","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0080","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/OLQ.0b013e318195762c","article-title":"Prevalence of HPV-DNA and anti-HPV antibodies in women from Girardot","volume":"36","author":"Leon","year":"2009","journal-title":"Colombia. Sex Transm Dis."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0085","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/ijc.25940","article-title":"Impact of an HPV6\/11\/16\/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16\/18 infection","volume":"129","author":"Haupt","year":"2011","journal-title":"IntJ Cancer."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0090","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1086\/522869","article-title":"Human papillomavirus vaccine should be given before sexual debut for maximum benefit","volume":"196","author":"Hildesheim","year":"2007","journal-title":"J Infect Dis."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0095","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/OLQ.0b013e3181e1a2c5","article-title":"Seroprevalence and correlates of human papillomavirus 16\/18 seropositivity among young women in Costa Rica","volume":"37","author":"Coseo","year":"2010","journal-title":"Sex Transm Dis."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0100","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.bjc.6601272","article-title":"Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10 000 women in Costa Rica","volume":"89","author":"Wang","year":"2003","journal-title":"BrJ Cancer."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0105","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1258\/095646203321264872","article-title":"Epidemiologic correlates of antibody response to human papillomavirus among women at low risk of cervical cancer","volume":"14","author":"Nonnenmacher","year":"2003","journal-title":"Int J STD AIDS."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0110","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1128\/JCM.01322-07","article-title":"Cervical human papillomavirus (HPV) infection and HPV type 16 antibodies in South African women","volume":"46","author":"Marais","year":"2008","journal-title":"J Clin Microbiol."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0115","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1128\/CVI.00441-09","article-title":"Progesterone and 17beta-estradiol enhance regulatory responses to human papillomavirus type 16 virus-like particles in peripheral blood mononuclear cells from healthy women","volume":"17","author":"Marks","year":"2010","journal-title":"Clin Vaccine Immunol."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0120","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/00365540801995360","article-title":"Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection","volume":"40","author":"Simen-Kapeu","year":"2008","journal-title":"Scand J Infect Dis."},{"key":"10.1097\/IGC.0b013e31823c2469_bb0125","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/aje\/kwn354","article-title":"Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks","volume":"169","author":"Kapeu","year":"2009","journal-title":"Am J Epidemiol."},{"issue":"suppl 11","key":"10.1097\/IGC.0b013e31823c2469_bb0130","doi-asserted-by":"crossref","first-page":"L16","DOI":"10.1016\/j.vaccine.2008.06.008","article-title":"Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean","volume":"26","author":"Almonte","year":"2008","journal-title":"Vaccine."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24058432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24058432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:13:09Z","timestamp":1753233189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24058432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1048891X24058432"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e31823c2469","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age-Specific Seroprevalence of Human Papillomavirus 16, 18, 31, and 58 in Women of a Rural Town of Colombia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e31823c2469","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}